Discover the range of academic oncology titles at Springer Nature here.
Breast Cancer Risk Factors
Breast Cancer Research is presenting our Retrospective Collection on "Breast Cancer Risk Factors." Celebrating 'Breast Cancer Awareness Month (1 October- 31 October)', with this Collection, we aim to gain valuable insights into the multifaceted aspects of breast cancer risk to promote awareness, prevention, and early detection.
Aims and scope
Articles
-
-
Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancer
-
Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients
-
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study
-
Wearable device for axillary lymph node screening in breast cancer based on infrared thermography and artificial intelligence
-
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib
-
Choosing the right cell line for breast cancer research
-
Triple-negative breast cancer molecular subtyping and treatment progress
-
Breast asymmetry and predisposition to breast cancer
-
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
Editor-in-Chief
Lewis Chodosh, University of Pennsylvania, USA
Trending in the Media
Click here to see the most popular articles published in Breast Cancer Research in the past three months.
BCR's 20th Anniversary
20 years ago Breast Cancer Research published its first articles with BMC. Well-respected in the field, the journal has continually placed in the first quartile of the ‘Oncology’ category of Journal Citation Reports. Over the past decade, Breast Cancer Research (BCR) has also become the highest ranked breast cancer focused title in the field.
Look back at the journal’s milestone achievements and article highlights.
Featured Review - Artificial intelligence in mammographic phenotyping of breast cancer risk: a narrative review
In this review, we provide a useful reference for AI researchers investigating image-based breast cancer risk assessment while indicating key priorities and challenges that, if properly addressed, could accelerate the implementation of AI-assisted risk stratification to future refine and individualize breast cancer screening strategies.
Springer Nature Oncology Portfolio
Follow
Annual Journal Metrics
-
Citation Impact
Journal Impact Factor: 6.1 (2023)
5-year Journal Impact Factor: 7.1 (2023)
Source Normalized Impact per Paper (SNIP): 1.412 (2024)
SCImago Journal Rank (SJR): 2.202 (2024)
Speed
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 145
Usage 2024
Downloads: 2,971,481
Altmetric mentions: 1,091